8-K Announcements
6Material company update
Mar 16, 2026·SEC
Material company update
Mar 6, 2026·SEC
Material company update
Mar 3, 2026·SEC
Quipt Home Medical Corp.(QIPT)Earnings, Financials & Key Ratios
QIPT•NASDAQ
$3.65
Price updated Jun 20, 2026
AboutQuipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. In addition, it provides nebulizers, oxygen concentrators, CPAP and BiPAP units, ventilator equipment and aids, daily and ambulatory aides, equipment solutions, power wheelchairs, oxygen therapy, bariatric equipment, bathroom safety products, bilevel positive airway pressure, canes/crutches, continuous positive airway pressure, CPAP masks and accessories, hospital beds, humidifiers, compressors, patient lifts, walkers, products for wound care, and medical equipment for home-based sleep apnea and chronic obstructive pulmonary disease treatments, as well as rents respiratory equipment. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.Show more
- Revenue$245M-0.2%
- EBITDA$42M-19.0%
- Net Income-$11M-58.2%
- EPS (Diluted)-0.25-56.3%
- Gross Margin97.53%+35.5%
- EBITDA Margin17.05%-18.9%
- Operating Margin-1.56%-443.6%
- Net Margin-4.36%-58.6%
- ROE-9.76%-57.5%
QIPT Price & Volume
Quipt Home Medical Corp. (QIPT) stock price & volume — 10-year historical chart
Loading chart...
Inconsistent Organic Growth Masks Persistent Net Losses
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Mixed
Profitability:Negative
Financial:Strained
Cash Flow:Mixed
Primary Risk:Regulatory reimbursement and integration
Key Thesis Takeaways
- Quipt Home Medical Corp.
- faces significant structural challenges as it attempts to transition from an acquisition-led growth model to sustainable profitability.
- While the company has achieved revenue growth of 34.0% in 2026Q1, the persistent inability to convert this into positive net income, evidenced by a $1.1 million loss in the same period, raises concerns regarding long-term scalability.
- Investors should monitor the company's high debt-to-equity ratio of 1.13 and the potential for goodwill impairment given the $61.6 million currently carried on the balance sheet.
Verdict Logic
the company's inability to generate positive net income, combined with a concerning debt-to-equity ratio of 1.13 and a reliance on inorganic growth, suggests significant execution risk for prospective investors.
QIPT Growth Metrics
Quipt Home Medical Corp. (QIPT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years16.47%
5 Years27.38%
3 Years20.61%
TTM19.78%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-61.83%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-56.12%
Return on Capital
10 Years-7.39%
5 Years1.25%
3 Years0.97%
Last Year-1.83%
QIPT Recent Earnings
Quipt Home Medical Corp. (QIPT) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 2/12 qtrs (17%)●Beat Revenue 1/12 qtrs (8%)
Q1 2026Latest
Feb 10, 2026Metric
Actual
Est
EPS
$0.02+80.0%
$0.10
Rev
$76M+0.0%
$76M
Q4 2025
Dec 15, 2025Metric
Actual
Est
EPS
$0.08-152.6%
$0.03
Rev
$68M-35.7%
$105M
Q3 2025
Aug 11, 2025Metric
Actual
Est
EPS
$0.07-2.1%
$0.07
Rev
$43M-51.3%
$87M
Q2 2025
May 12, 2025Metric
Actual
Est
EPS
$0.07-450.0%
$0.02
Rev
$40M-54.6%
$88M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 10, 2026 | $0.02vs $0.10+80.0% | $76Mvs $76M+0.0% |
| Q4 2025 | Dec 15, 2025 | $0.08vs $0.03-152.6% | $68Mvs $105M-35.7% |
| Q3 2025 | Aug 11, 2025 | $0.07vs $0.07-2.1% | $43Mvs $87M-51.3% |
| Q2 2025 | May 12, 2025 | $0.07vs $0.02-450.0% | $40Mvs $88M-54.6% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Quipt Home Medical Corp. (QIPT)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $3.65 | $160.7M | -14.60 | -0.23% | -4.36% | -9.76% | — | |
| $24.62 | $1.69B | 30.40 | 7.08% | 3.67% | 13.6% | — | |
| $13.80 | $706.91M | -152.32 | 2.44% | -0.3% | -0.55% | — | |
| $73.15 | $1.43B | -7.52 | -43.89% | -284.18% | -87% | — | |
| $21.82 | $1.61B | 6.61 | 18.52% | 118.91% | 47.59% | — | |
| $54.11 | $1.72B | 83.25 | 17.76% | 4.11% | 11.72% | — |
Compare QIPT vs Peers
Quipt Home Medical Corp. (QIPT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
QIPT SEC Filings & Documents
Quipt Home Medical Corp. (QIPT) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when QIPT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
QIPT Frequently Asked Questions
Quipt Home Medical Corp. (QIPT) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Quipt Home Medical Corp.'s revenue?
Quipt Home Medical Corp. (QIPT) reported $286.6M in revenue for fiscal year 2025.
How fast is Quipt Home Medical Corp. growing?
Quipt Home Medical Corp. (QIPT) saw revenue decline by 0.2% over the past year.
Is QIPT profitable?
Quipt Home Medical Corp. (QIPT) reported a net loss of $10.7M for fiscal year 2025.
Dividend & Returns
What is QIPT's return on equity?
Quipt Home Medical Corp. (QIPT) has a return on equity (ROE) of -9.8%. Negative ROE indicates the company is unprofitable.
What is Quipt Home Medical Corp.'s free cash flow?
Quipt Home Medical Corp. (QIPT) generated $26.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.